WCN24-2644 VITAMIN B COMPLEX IN LIVING KIDNEY DONORS

Simple item page
dc.contributor.authorI.S.R.A.E.L. RIVAS
dc.contributor.authorM.A.B.E.L. MERIDA
dc.contributor.authorDionicia Zeballos
dc.contributor.authorCarlos Agustín León Román
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T19:15:29Z
dc.date.available2026-03-22T19:15:29Z
dc.date.issued2024
dc.description.abstractThe practice of kidney transplantation enhances the quality of life and improves the rates of survivance in patients with chronical renal diseases. In the case of a kidney transplant with a living donor, different mechanisms are being sought to improve residual renal function. Preclinical studies have identified the upregulation of NAD+ as a potential strategy for the prevention and treatment of AKI (acute kidney injury). NAD+ is the final metabolized form of vitamin B3. A recent clinical study found that COVID-19-related AKI was associated with NAD+ biosynthetic impairment arising in the context of ischemic, inflammatory, or toxic kidney injury.
dc.identifier.doi10.1016/j.ekir.2024.02.1050
dc.identifier.urihttps://doi.org/10.1016/j.ekir.2024.02.1050
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/74986
dc.language.isoen
dc.publisherElsevier BV
dc.relation.ispartofKidney International Reports
dc.sourceBolivia Adventist University
dc.subjectMedicine
dc.subjectKidney
dc.subjectVitamin D and neurology
dc.subjectIntensive care medicine
dc.subjectPhysiology
dc.titleWCN24-2644 VITAMIN B COMPLEX IN LIVING KIDNEY DONORS
dc.typearticle

Files

Collections

Artículo Científico Publicado